Connect Biopharma Holdings (CNTB) Receivables - Net (2024 - 2026)

Connect Biopharma Holdings has disclosed Receivables - Net across 3 years of filings, most recently posting $2.9 million for Q2 2026.

• In Q2 2026, Receivables - Net changed N/A year-over-year to $2.9 million; the TTM figure through Jun 2026 stood at $2.9 million (changed N/A YoY), while the FY2025 annual figure was $13000.0, down 98.35% from the prior year.
• Receivables - Net came in at $2.9 million for Q2 2026 at Connect Biopharma Holdings, up from $13000.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $2.9 million in Q2 2026 to a low of $8000.0 in Q1 2025.
• Average Receivables - Net over 3 years is $752600.0, with a median of $17000.0 recorded in 2025.
• The largest YoY upside for Receivables - Net was 98.35% in 2025 against a maximum downside of 98.35% in 2025.
• Over 3 years, Receivables - Net stood at $789000.0 in 2024, then sank by 98.35% to $13000.0 in 2025, then soared by 22484.62% to $2.9 million in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $2.9 million in Q2 2026, $13000.0 in Q4 2025, and $17000.0 in Q3 2025.